Revolutionising the future of musculoskeletal therapeutics
Myomakers core technology is bioengineered human musculoskeletal tissues with a wide range of applications. These tissues accurately replicate the structure and function of human muscle, making them an ideal platform to model human physiology, providing an animal free alternative to current preclinical models used within drug discovery.
Our Expertise
Professor Mark Lewis’ research group at Loughborough University has over 50 combined years’ experience of developing and refining biomimetic skeletal muscle models derived from human cells.
Myomakers Expert Team
Our team have collaborated on multiple research projects at Loughborough University
Professor Mark Lewis
CEO
Dr Andrew Capel
CSO
Tim King
CFO
Dr Kerry Chaplin
CBO
Dr Rowan Rimington
Advisor / Non Exec Director